Roivant Sciences Ltd.
NASDAQ:ROIV · NASDAQ Global Market
+$0.21 today
Vol 7.06M · Avg 5.62M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+173.30%
Period High
$32.41
Period Low
$10.74
Latest
$31.43
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Revolution Medicines, Inc.
NASDAQ:RVMD
$34.81B
Moderna, Inc.
NASDAQ:MRNA
$25.32B
Royalty Pharma plc
NASDAQ:RPRX
$22.71B
Exact Sciences Corporation
EXAS
$20.03B
Ascendis Pharma A/S
NASDAQ:ASND
$14.38B
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
$14.06B
BridgeBio Pharma, Inc.
NASDAQ:BBIO
$12.99B
Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
$12.26B
Summit Therapeutics Inc.
NASDAQ:SMMT
$10.65B
Atrium Therapeutics, Inc.
NASDAQ:RNA
$216.64M
What is the latest ROIV filing?
The latest filing shown is 4 dated May 22, 2026.
How many recent filings does ROIV have?
Intrinsic Alpha currently shows 20 recent filings for ROIV.
Explore More
Continue the stock analysis
Jump to another research area for this company.